Close close


Enter your search term below:



£200K SEIS funding puts Fourth State Medicine on the path to success

Surrey SETsquared member, Fourth State Medicine, has recently benefitted from an injection of £200K seed investment to accelerate the development of their product.

Leveraging state of the art space technology, Fourth State Medicine has created a wrinkle-busting hand-held plasma pen for use in cosmetic surgery. This same product can also be used to treat ulcers, burns, bedsores and wounds.

The investment comes from three different sources, a private investor whom the company met at SETsquared’s annual Investment Showcase in 2014, the Oxford Investment Opportunity Network Ltd and from the NHS.

Dr Tom Frame, CEO of Fourth State Medicine, says: “This investment is essential to the development of our product. As a medical device, there are many regulatory standards that we must comply with and we need to work on the aesthetics and ergonomics of the product. We’re looking at a full commercial launch in early 2016, which is really exciting.”

The plasma pen is already endorsed by several Harley Street surgeons and academics, thanks to the fact that it is the only device that can address deep periocular and upper lip area and could revolutionise the multi-billion skin resurfacing and wrinkle removal market.

It also has the potential for sterilisation and elimination of MRSA for wound care, and for the sterilisation and alleviation of symptoms in diabetic ulcers, which will be highly beneficial and positive for the healthcare industry.

Find out more about Fourth State Medicine

Close close

Mailing List sign-up

  • By submitting this form you agree to our privacy policy


twitter twitter
Follow Us

SETsquared is a partnership between

  • University of Bath
  • University of Bristol
  • University of Exeter
  • University of Southampton logo
  • University of Surrey